|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ALEC | Romano Gary | Chief Medical Officer | Dec 02 '24 | Sale | 2.52 | 14,892 | 37,519 | 349,283 | Dec 03 05:40 PM |
ALEC | Gary Romano | Officer | Dec 02 '24 | Proposed Sale | 2.59 | 14,306 | 37,053 | Nov 29 03:00 PM | |
ALEC | Romano Gary | Chief Medical Officer | Sep 03 '24 | Sale | 4.88 | 8,478 | 41,385 | 179,795 | Sep 04 04:15 PM |
ALEC | Gary Romano | Officer | Sep 03 '24 | Proposed Sale | 5.28 | 7,788 | 41,121 | Aug 30 05:18 PM | |
ALEC | Romano Gary | Chief Medical Officer | Jun 03 '24 | Sale | 4.80 | 8,040 | 38,582 | 188,273 | Jun 04 06:05 PM |
ALEC | Romano Gary | Chief Medical Officer | Mar 04 '24 | Sale | 6.92 | 6,001 | 41,554 | 196,313 | Mar 05 06:00 PM |
ALEC | Romano Gary | Chief Medical Officer | Dec 04 '23 | Sale | 5.56 | 5,035 | 27,995 | 202,314 | Dec 06 06:30 PM |
ALEC | Romano Gary | Chief Medical Officer | Sep 05 '23 | Sale | 5.19 | 2,771 | 14,393 | 99,349 | Sep 06 07:16 PM |
ALEC | Romano Gary | Chief Medical Officer | Jun 02 '23 | Sale | 6.90 | 2,617 | 18,067 | 102,120 | Jun 05 06:50 PM |
ALEC | Romano Gary | Chief Medical Officer | Dec 02 '22 | Sale | 8.71 | 2,145 | 18,679 | 107,975 | Mar 03 08:56 PM |
ALEC | Romano Gary | Chief Medical Officer | Mar 02 '23 | Sale | 8.32 | 3,238 | 26,933 | 104,737 | Mar 03 08:56 PM |
ALEC | Romano Gary | Chief Medical Officer | Sep 02 '22 | Sale | 10.62 | 2,177 | 23,120 | 90,073 | Sep 07 04:17 PM |
PASG | Romano Gary | Chief Medical Officer | Mar 15 '21 | Option Exercise | 8.07 | 10,000 | 80,700 | 10,000 | Mar 17 09:12 PM |
PASG | Romano Gary | Chief Medical Officer | Mar 15 '21 | Sale | 21.10 | 10,000 | 211,013 | 0 | Mar 17 09:12 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite